Genetic profiling of late radiation toxicity in patients with prostate cancer

• Conditions: prostate cancer; side-effects; 10038588

• Registration Number: NL-OMON35092
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 80

Inclusion Criteria

adult males at leats 2 years after curative radiotherapy for prostate cancer
no evidence of prostate cancer
two groups are selected:
with severe toxicity (SOMA grade 3-4), or
with no or mild toxicity (grade 0-1)

Exclusion Criteria

- patients who had prostatectomy or brachytherapy
- patients with severe mental or somatic disorders

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- gene expression profile in lymphocytes<br /><br>- toxicity questionnaire</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>-</p><br>